Illumina Announces Strategic Relaunch with New Leadership and Governance Structure

Illumina, Inc. released a management-focused presentation for investors on its investor relations website on Wednesday. The presentation addressed several key issues of investor focus, including updates to the board and team, the executive compensation system, andGRAILAnd other regulatory processes.

First, the basic situation of the company: more than ten thousand employees,155National9500Multiple clients,23000Total Sequencers Installed in Taiwan, Last Year's Revenue45.5Billion USD, invested in R&D10Billion USD. Compound growth over the past five years11%, Annual Revenue in China70%The above comes from consumables (library preparation and sequencing kits, including flow cells, reagents, etc.),15%The above comes from the revenue of instruments, and the rest comes from service and other revenues. (Do you know here?ServiceDoes it refer to something? The answer is at the end of the article.）

Illumina Welcomes New Board of Directors and Core Management Team

In the past few months, IlluminaAppointed a new director as chairman, the board added four new members (two departed). The experience and governance structure of the new board are more robust and powerful.

It is worth mentioning that,Newly AppointedCEOStarted working two weeks ago.. Illumina, Inc. also announcedCEOStrict Requirements and Procedures for Selection.

• Distinguished individuals serving as CEO, COO, or Business Unit President (reporting to the CEO), with expertise in equipment and life sciences technologies (with a focus on genomics)./Diagnostic Experience/Experience in the field of knowledge

• A proven track record of success in developing domestic and global markets (including China)

• Promote Innovation (Ph.D. preferred)/MD) and a track record of financial growth and business expansion

• Building a History of Team Delivery Performance, Converted into Revenue and Valuation

• Experience and Favorable Solutions in Cooperation with Regulatory Authorities

• And Illumina A similar history of revenue drivers (i.e., in tools and clinical aspects)

• As an important success history of the operator

Illumina Nomination/The Corporate Governance Committee oversaw the entire process, and the company also utilized a third-party headhunting firm to recruit and screen candidates. 297 Internal and external candidates, including3 The shortlisted candidates were interviewed by all members of the board., ultimately appointing Jacob·Dr. Saisen for the newCEO。

New CEO Compensation Structure Focuses on Performance Incentives

• Pay for Performance - Linking compensation to the company's short-term, medium-term, and long-term performance

• Aligned Interests - Strengthen the Relationship Between Compensation and Shareholder Value

• Competitive Rewards - Actions to Reward Individual Creativity

• Retention - Attract, Retain, and Reward Top Talent Who Contribute

Designed new based on shareholder feedbackCEOThe salary structure and compensation plan are consistent with the company's executive compensation philosophy. Ultimately, the risk payment component accounts for92%。

Awaiting PeelingGRAIL

2016 Year,Illumina Peeling Off GRAIL, raising approximately 20 Billion US dollars.2021Year6Month,GRAILLaunch of the First Multi-Cancer Early Detection Test in the United StatesGalleri。2021 Year 8 Month 18 Day,Illumina Re-acquired the previously divested GRAIL, Aiming to utilizeIlluminaResource Acceleration Galleri Testing the global availability and affordability. Since the re-acquisition, as of 2023 Year # 2 Quarter,GRAILCumulative revenue has reached 1.09 billion dollars. During the period of pending regulatory review and related legal procedures,GRAILIndependent of Illumina Operation.

IlluminaShowcasedGRAILPossible Outcomes Under Regulatory Review Results.

If it loses the appeal in the U.S. Fifth Circuit Court or the EU jurisdiction (either loss),IlluminaWill be carried out rapidlyGRAILAsset Stripping; If Winning Two Pending Cases,IlluminaWill be fully re-evaluated GRAIL The asset portfolio, which may lead to the integration or divestiture of part or all of it. GRAIL, in order to maximize shareholder value.

This means that,IlluminaIt will probably wait until the final verdicts from both courts are out before proceeding with the (highly likely) divestiture.GRAIL。And this could happen by the end of this year.

IlluminaThe services provided by its laboratories, system warranty and maintenance contracts, as well as revenue from intellectual property fees, in vitro diagnostic licenses, milestones, and informatics were all categorized.“Services and Others”Category.